Methadone Clinics in Rhode Island

Methadone clinics in Rhode Island provide supportive assistance to those who are addicted to heroin or prescription painkillers offering helpful ways to recover without withdrawal or cravings.

Methadone Clinics in cities of Rhode Island

Medication Treatment for Opioid Use Disorder Across Rhode Island

Rhode Island is small enough to cross in under an hour, and that compactness shapes how opioid use disorder (OUD) care works here. Opioid treatment programs cluster in and around Providence, Pawtucket, and Woonsocket, while telehealth and take-home dosing reach the people a daily clinic visit would not.

The state has treated its overdose crisis as a public health priority for more than a decade and was an early national leader in medication for opioid use disorder (MOUD). All three FDA-approved medications, methadone, buprenorphine (including Suboxone), and naltrexone, are available through both clinics and office-based prescribers.

The listings on this page connect you to providers across the state, and the site helpline can help you find a first appointment.

The Three Medications and Where You Get Each One

Treatment for opioid use disorder centers on three medications, and knowing how each is dispensed tells you what the listings on this page represent.

Methadone is a full opioid agonist that steadies withdrawal and cravings. For OUD, it is dispensed only through a licensed opioid treatment program (OTP), not a regular pharmacy, so dosing starts on-site and moves toward take-home doses as treatment stabilizes.

Buprenorphine, including Suboxone (buprenorphine-naloxone) and extended-release injectable forms such as Sublocade, is a partial agonist with a ceiling effect that lowers overdose risk. Since 2023, any clinician with a standard DEA registration that includes Schedule III authority can prescribe it, subject to state law, so you can get it in a doctor’s office (office-based opioid treatment, or OBOT) and fill it at a pharmacy, or through an OTP. You can compare how methadone and Suboxone differ in daily routine and effect before you decide.

Naltrexone, including the monthly Vivitrol injection, blocks opioid effects rather than easing withdrawal. Any licensed provider can prescribe it, but you have to be off opioids for a set period first, or starting it can trigger sudden, severe withdrawal. Which medication fits is a decision to make with a clinician. To learn background information, the details of how methadone treatment works and the difference between clinic-based and office-based OTP care are worth reading first.

State Rules, Coverage, and Funding in Rhode Island

Rhode Island’s Medicaid program runs mainly through RIte Care, its managed care system, delivered by Neighborhood Health Plan of Rhode Island and UnitedHealthcare of New England, and Medicaid covers medication treatment for opioid use disorder.

Because Medicaid provides full coverage for methadone, Rhode Islanders on Medicaid access it at rates well above the national average, though the Federal Reserve Bank of Boston has noted some buprenorphine prescribers decline Medicaid over reimbursement, which can affect where office-based care is available.

The state also built a distinctive delivery model. Through its Medicaid OTP Health Home and Centers of Excellence framework, approved by CMS in 2016, programs offer expedited access and bundled support services alongside medication.

Federal rules that took effect in 2024 (a revision of 42 CFR Part 8) expanded take-home methadone up to a 28-day supply for stable patients, allowed treatment to begin by telehealth, and removed the old requirement of a one-year addiction history before admission.

Take-home eligibility is decided by the program based on your stability in treatment. As of July 2026, buprenorphine can also be started through telehealth, including by phone in many cases, without a prior in-person visit. Those flexibilities run through the end of 2026 and are still being finalized, so confirm current options with a provider.

Methadone for OUD remains dispensed through an OTP, though some programs can begin treatment with a telehealth visit. Anyone worried about work or privacy can review how treatment intersects with employment, and staying consistent with a dose matters, which is why programs emphasize dosage continuity.

Rhode Island’s Overdose Picture

The trend here has moved in an encouraging direction. According to the Rhode Island Department of Health, 219 people died of an accidental overdose in 2025, down from 329 in 2024 and 436 in 2022, the lowest count since before 2013 and a roughly 50% drop over three years that put the state past its 2030 reduction goal early.

Fentanyl remained the largest driver, involved in 57% of 2025 deaths, usually alongside another substance. The figures still represent real loss in Rhode Island communities, but they also reflect what a sustained, coordinated response can do, and effective treatment is available locally right now. For context on how these medications fit into recovery, see this overview of opioid use disorder and the paths out of it.

How to Start Treatment and Find a Program Near You

Starting begins with an intake assessment, where a provider reviews your history and, for methadone or buprenorphine, plans the timing of your first dose. That timing matters most if you have been using fentanyl, because starting buprenorphine too soon can bring on precipitated withdrawal, so a clinician plans induction around your last use.

Some Rhode Island programs offer same-day or next-day starts, and telehealth can bridge the gap while you arrange ongoing in-person care. Because the state is compact, a program in a neighboring city is rarely far, which helps when your nearest OTP has a waitlist.

Use the listings on this page to reach a provider directly, or the site helpline for help choosing a first step. If you want to understand the fuller range of care, including when a residential setting may fit, this guide to outpatient and other opioid treatment options and the note on how inpatient care differs can help you compare.

Treatment for Justice-Involved and Pregnant Rhode Islanders

Rhode Island is a national reference point for treating opioid use disorder in the justice system. Since 2016, the Rhode Island Department of Corrections has run the country’s first statewide program to screen everyone entering custody for OUD and offer all three medications. Research published in the Lancet-affiliated literature tied the program to a 60.5% reduction in post-release overdose mortality among recently incarcerated people.

If you or someone you love is leaving incarceration, continuity of medication through release is both expected and protective, and community programs are set up to receive that handoff. For pregnant patients, medication treatment is the recommended standard of care, and RIDOC continues methadone through pregnancy for those already in treatment.

Rhode Island Medicaid covers prenatal care through RIte Care, and treatment during pregnancy is coordinated to protect both parent and baby, including planning for neonatal opioid withdrawal syndrome. Families supporting someone through this can read how methadone is managed during pregnancy and how to help a loved one start and stay in treatment.

Naloxone and Staying Safe

Naloxone, the medication that reverses an opioid overdose, is available over the counter at Rhode Island pharmacies and free through harm reduction organizations. Prevent Overdose RI ships it free to state residents, and community groups and pharmacies distributed 55,557 naloxone kits in 2025. Rhode Island’s Good Samaritan Act, made permanent in 2016, offers legal protection to people who call 911 during an overdose.

The state has also invested in on-the-ground harm reduction, including the nation’s first state-regulated harm reduction center at Project Weber/RENEW in Providence. A return to use is a common, manageable part of recovering from a chronic condition, not a failure. Keeping naloxone nearby is basic safety. For how overdose risk works with these medications, see this explainer on methadone and overdose safety.

Common Questions About Treatment in Rhode Island

Does Rhode Island Medicaid cover methadone and Suboxone?

Yes, Rhode Island Medicaid, largely delivered through RIte Care managed care plans, covers medication for opioid use disorder, and it fully covers methadone through opioid treatment programs. Coverage details and any prior authorization can vary by plan, so confirm specifics with your plan or the program you choose.

Do I have to go to a clinic every day for methadone?

At first, methadone is usually dosed on-site at an OTP. Federal rules updated in 2024 allow take-home supplies of up to 28 days for patients who are stable in treatment, on a graduated schedule, with eligibility decided by the program. Daily visits are a starting point, not a permanent requirement.

Can I start Suboxone by telehealth in Rhode Island?

In many cases, yes. As of July 2026, buprenorphine can be started through telehealth, including by phone in defined circumstances, without a prior in-person visit. These flexibilities run through the end of 2026 and are still being finalized, so confirm current options with a provider.

What is the difference between methadone and Suboxone?

Methadone is a full opioid agonist dispensed through an OTP. Suboxone contains buprenorphine, a partial agonist with a ceiling effect that lowers overdose risk, and can be prescribed in an office and filled at a pharmacy. Which fits depends on your history and needs, a decision to make with a clinician. You can read a fuller comparison of the two.

Is it safe to take methadone long term?

Long-term medication treatment is legitimate, effective care, and many people stay on it for years. Whether and when to taper is an individual decision made with a provider. For more, see what treatment completion can look like and whether taking methadone as prescribed constitutes addiction.

Sources and Disclosures

Last reviewed July 2026.

Sources:

Rhode Island Department of Health / Governor’s Office, 2025 overdose death data (announcement) and Prevent Overdose RI (overdose data, naloxone access).
Rhode Island Executive Office of Health and Human Services / Medicaid, OTP Health Home and Centers of Excellence model (program description).
Federal Reserve Bank of Boston, Rhode Island MAT access analysis (interview).
Brandeis Opioid Resource Connector and peer-reviewed research on the RIDOC correctional MOUD program (program model).
SAMHSA and DEA on federal MOUD rules, 42 CFR Part 8 (2024), and buprenorphine telehealth (telemedicine rule) and the fourth temporary extension through 2026 (HHS notice).

Methadone Centers is a treatment-discovery and education platform, not a medical provider. The information here is educational and not a substitute for advice from a licensed clinician. No diagnosis, treatment recommendation, or outcome is guaranteed.

The helpline featured on this site is a paid advertising and referral service. Calls may be routed to a sponsoring treatment provider. Using it is not required to find care, and the provider listings on this page are available to contact directly.